相似文献
1
Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate.
Antimicrob Agents Chemother. 1979 Jun;15(6):758-62. doi: 10.1128/AAC.15.6.758.
2
Synergistic inhibition of anatid herpesvirus replication by acyclovir and phosphonocompounds.
Intervirology. 1987;28(2):89-99. doi: 10.1159/000150000.
3
Characteristics of herpes simplex virus resistance to disodium phosphonoacetate.
Intervirology. 1978;9(4):193-205. doi: 10.1159/000148937.
4
Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
Arch Virol. 1980;65(2):149-56. doi: 10.1007/BF01317326.
5
6
Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
Antimicrob Agents Chemother. 1980 Apr;17(4):558-66. doi: 10.1128/AAC.17.4.558.
7
Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: studies on its mode of action.
J Med Virol. 1980;5(4):309-16. doi: 10.1002/1096-9071(1980)5:4<309::aid-jmv1890050407>3.0.co;2-l.
8
Herpes simplex virus DNA polymerase as the site of phosphonoacetate sensitivity: temperature-sensitive mutants.
J Virol. 1977 Nov;24(2):470-7. doi: 10.1128/JVI.24.2.470-477.1977.
9
The antiherpesvirus action of phosphonoacetate.
Pharmacol Ther. 1979;4(1):231-43. doi: 10.1016/0163-7258(79)90021-4.
10
Altered biological and biochemical properties of a phosphonoacetate-resistant mutant of herpesvirus of turkeys.
IARC Sci Publ (1971). 1978(24 Pt 1):253-60.
引用本文的文献
1
Recent advances in cloning herpesviral genomes as infectious bacterial artificial chromosomes.
Cell Cycle. 2011 Feb 1;10(3):434-40. doi: 10.4161/cc.10.3.14708.
2
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.
Drugs. 1994 Aug;48(2):199-226. doi: 10.2165/00003495-199448020-00007.
3
Cooperative effects between two acyclovir resistance loci in herpes simplex virus.
J Virol. 1984 Jun;50(3):838-46. doi: 10.1128/JVI.50.3.838-846.1984.
4
Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.
Antimicrob Agents Chemother. 1983 Jun;23(6):914-7. doi: 10.1128/AAC.23.6.914.
5
9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication.
Antimicrob Agents Chemother. 1983 May;23(5):664-70. doi: 10.1128/AAC.23.5.664.
6
Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
Antimicrob Agents Chemother. 1982 Dec;22(6):1026-30. doi: 10.1128/AAC.22.6.1026.
7
A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2.
Antimicrob Agents Chemother. 1982 Jul;22(1):55-61. doi: 10.1128/AAC.22.1.55.
8
Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.
J Virol. 1982 Mar;41(3):909-18. doi: 10.1128/JVI.41.3.909-918.1982.
9
Selective inhibition of herpesvirus deoxyribonucleic acid synthesis by acycloguanosine, 2'-fluoro-5-iodo-aracytosine, and (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Antimicrob Agents Chemother. 1981 May;19(5):927-9. doi: 10.1128/AAC.19.5.927.
10
Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.
Arch Virol. 1981;68(3-4):203-9. doi: 10.1007/BF01314573.
本文引用的文献
1
CELL CULTURE STUDIES ON ANTIVIRAL AGENTS. I. ACTION OF CYTOSINE ARABINOSIDE AND SOME COMPARISONS WITH 5-IODO-2-DEOXYURIDINE.
Proc Soc Exp Biol Med. 1964 Jan;115:69-77. doi: 10.3181/00379727-115-28834.
2
Studies on herpes simplex. XI. The antiviral dynamics of 5-iodo-2-deoxyuridine in vivo.
J Immunol. 1965 Oct;95(4):635-42.
3
DNA-dependent DNA polymerases from HeLa cell nuclei. II. Template and substrate utilization.
Biochem Biophys Res Commun. 1971 Aug 20;44(4):879-85. doi: 10.1016/0006-291x(71)90793-5.
4
Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.
J Gen Virol. 1968 May;2(3):357-64. doi: 10.1099/0022-1317-2-3-357.
5
Rational design of arabinosyl nucleosides as antitumor and antiviral agents.
Jpn J Antibiot. 1977 Dec;30 Suppl:104-20.
6
A working hypothesis--virus resistance development as an indicator of specific antiviral activity.
Ann N Y Acad Sci. 1977 Mar 4;284:632-7. doi: 10.1111/j.1749-6632.1977.tb21997.x.
7
Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.
Antimicrob Agents Chemother. 1978 Sep;14(3):408-13. doi: 10.1128/AAC.14.3.408.
8
Trisodium phosphonoformate, a new antiviral compound.
Science. 1978 Sep 1;201(4358):819-21. doi: 10.1126/science.210500.
9
Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.
Antimicrob Agents Chemother. 1978 Feb;13(2):188-92. doi: 10.1128/AAC.13.2.188.
10
Characteristics of herpes simplex virus resistance to disodium phosphonoacetate.
Intervirology. 1978;9(4):193-205. doi: 10.1159/000148937.
Zotero 插件